Latest / Diabetes Connections | Type 1 Diabetes
In the News.. A partner for a T1D prevention drug, expanding CGM Medicare coverage, the worst age for T2D outcomes, and more!
It's It's "In the News…" a look at the top diabetes stories and headlines of the past seven days. This week: Provention Bio hopes to get FDA approval of Teplizumab next month and partners with Sanofi on this T1D prevention drug, new type 2 studies show that younger people who develop it generally have worse health outcomes, Medicare considers expanded coverage of CGMs and more
Learn more about the T1D Exchange: www.T1Dexchange.org/Stacey
Check out Stacey's book: The World's Worst Diabetes Mom!
Join the Diabetes Connections Facebook Group!
Sign up for our newsletter here
Episode Transcription…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.